Long-term efficacy and safety of moderate-intensity statin with ezetimibe combination therapy versus high-intensity statin monotherapy in patients with atherosclerotic cardiovascular disease (RACING): a randomised, open-label, non-inferiority trial

Prevalence of statin intolerance: a meta-analysis

(2022) Ibadete Bytyçi et al.   EUROPEAN HEART JOURNAL

Initial treatment with a single pill containing quadruple combination of quarter doses of blood pressure medicines versus standard dose monotherapy in patients with hypertension (QUARTET): a phase 3, randomised, double-blind, active-controlled trial

(2021) Clara K Chow et al.   LANCET

2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk

(2019) François Mach et al.   EUROPEAN HEART JOURNAL

Intensive LDL cholesterol-lowering treatment beyond current recommendations for the prevention of major vascular events: a systematic review and meta-analysis of randomised trials including 327 037 participants

(2019) Nelson Wang et al.   Lancet Diabetes & Endocrinology

2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol

(2018) Scott M. Grundy et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Safety and efficacy of statin therapy

(2018) Bhavin B. Adhyaru et al.   Nature Reviews Cardiology

Low-density lipoprotein cholesterol targeting with pitavastatin + ezetimibe for patients with acute coronary syndrome and dyslipidaemia: the HIJ-PROPER study, a prospective, open-label, randomized trial

(2017) Nobuhisa Hagiwara et al.   EUROPEAN HEART JOURNAL

Statin Intolerance and Risk of Coronary Heart Events and All-Cause Mortality Following Myocardial Infarction

(2017) Maria-Corina Serban et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease

(2017) Marie D. Gerhard-Herman et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Adherence to High-Intensity Statins Following a Myocardial Infarction Hospitalization Among Medicare Beneficiaries

(2017) Lisandro D. Colantonio et al.   JAMA Cardiology

2016 ESC/EAS Guidelines for the Management of Dyslipidaemias

(2016) Alberico L. Catapano et al.   EUROPEAN HEART JOURNAL

Evaluation and Treatment of Patients With Lower Extremity Peripheral Artery Disease

(2015) Manesh R. Patel et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Ezetimibe and Plaque Regression∗

(2015) Filippo Crea et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Impact of Dual Lipid-Lowering Strategy With Ezetimibe and Atorvastatin on Coronary Plaque Regression in Patients With Percutaneous Coronary Intervention

(2015) Kenichi Tsujita et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes

(2015) Christopher P. Cannon et al.   NEW ENGLAND JOURNAL OF MEDICINE

Effectiveness of Combination Therapy With Statin and Another Lipid-Modifying Agent Compared With Intensified Statin Monotherapy

(2014) Kimberly A. Gudzune et al.   ANNALS OF INTERNAL MEDICINE

Achieving goal lipid levels with ezetimibe plus statin add-on or switch therapy compared with doubling the statin dose. A pooled analysis

(2014) Baishali M. Ambegaonkar et al.   ATHEROSCLEROSIS

Higher potency statins and the risk of new diabetes: multicentre, observational study of administrative databases

(2014) C. R. Dormuth et al.   BMJ-British Medical Journal

Clinical outcome endpoints in heart failure trials: a European Society of Cardiology Heart Failure Association consensus document

(2013) Faiez Zannad et al.   EUROPEAN JOURNAL OF HEART FAILURE

An Updated Definition of Stroke for the 21st Century

(2013) Ralph L. Sacco et al.   STROKE

Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials

(2010)   LANCET

Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials

(2010) Naveed Sattar et al.   LANCET

Review of Side-Effect Profile of Combination Ezetimibe and Statin Therapy in Randomized Clinical Trials

(2008) Amir Kashani et al.   AMERICAN JOURNAL OF CARDIOLOGY